Inicio>>Analytical Standards>>5-fluoro JWH 018 adamantyl analog

5-fluoro JWH 018 adamantyl analog

Catalog No.GC42519

JWH 018 adamantyl is an analog of JWH 018, a mildly selective agonist of the peripheral cannabinoid (CB) receptor, where the naphthalene ring is substituted with an adamantyl group.

Products are for research use only. Not for human use. We do not sell to patients.

5-fluoro JWH 018 adamantyl analog Chemical Structure

Cas No.: 1364933-62-9

Tamaño Precio Disponibilidad Cantidad
1mg
111,00 $
Disponible
5mg
502,00 $
Disponible
10mg
891,00 $
Disponible

Tel:(909) 407-4943 Email: sales@glpbio.com

Reseñas de cliente

Based on customer reviews.

  • GlpBio Citations

    GlpBio Citations
  • Bioactive Compounds Premium Provider

    Bioactive Compounds Premium Provider

Sample solution is provided at 25 µL, 10mM.

Description Chemical Properties Product Documents Related Products

JWH 018 adamantyl is an analog of JWH 018, a mildly selective agonist of the peripheral cannabinoid (CB) receptor, where the naphthalene ring is substituted with an adamantyl group. Adamantyl substitutions provide structural rigidity and bulk. Though no biological activity has been reported for JWH 018 adamantyl, δ8-THC analogs with adamantyl substituted for the carbon side chain demonstrate improved affinity and selectivity of central CB1 and peripheral CB2 binding. 5-fluoro JWH 018 adamantyl analog is a derivative of JWH 018 adamantyl , having a fluorine atom at the terminal carbon of the pentyl chain. The physiological and toxicological properties of this compound are not known. This product is intended for forensic and research applications.

Reseñas

Review for 5-fluoro JWH 018 adamantyl analog

Average Rating: 5 ★★★★★ (Based on Reviews and 32 reference(s) in Google Scholar.)

5 Star
100%
4 Star
0%
3 Star
0%
2 Star
0%
1 Star
0%
Review for 5-fluoro JWH 018 adamantyl analog

GLPBIO products are for RESEARCH USE ONLY. Please make sure your review or question is research based.

Required fields are marked with *

You may receive emails regarding this submission. Any emails will include the ability to opt-out of future communications.